Why Was Oxbryta Recalled in 2024?
In September 2024, Oxbryta (voxelotor), a medication for sickle cell disease, was recalled due to safety risks that outweighed the benefits for patients. All active clinical trials involving Oxbryta were also stopped.
Pfizer, Inc. recalled Oxbryta after finding the medication increased the rate of vaso-occlusive crisis in patients with sickle cell disease. In one treatment group, more patients died than patients in the placebo group.
Now, families across the country are filing Oxbryta lawsuits against the manufacturer of this medication. These lawsuits claim the company knew or should’ve known about the dangers of this medication — but failed to warn patients.
At Sokolove Law, we’ve secured over $1.6 Billion for clients injured by dangerous drugs and medical devices. Find out if we can seek justice for your family.
Get the Help You Deserve
Our experienced attorneys may be able to file an Oxbryta lawsuit and fight for compensation on your behalf. See if you qualify now.
Who Can File an Oxbryta Recall Lawsuit?
You may be able to file an Oxbryta recall lawsuit if you or a loved one:
- Took Oxbryta to treat sickle cell disease
- Experienced an increased rate of vaso-occlusive crises (VOCs) or related complications
There’s only a limited amount of time to file a lawsuit for Oxbryta injuries due to state laws called statutes of limitations.
Once this deadline passes, you won’t be able to take legal action and pursue a settlement for your injuries again.
Call (800) 995-1212 now to see if you have a case before it’s too late. It costs nothing to speak with us.
Complications Caused by Oxbryta
Oxbryta works by helping red blood cells carry more oxygen, aiming to reduce the breakdown of these cells and improve blood flow in patients with sickle cell disease.
However, it may also raise the risk of vaso-occlusive crisis (VOC). This painful condition occurs when sickle-shaped blood cells get stuck in blood vessels, blocking blood flow and preventing oxygen and nutrients from reaching important organs.
VOCs from Oxbryta may increase the risk of:
- Acute chest syndrome
- Pulmonary embolism
- Pulmonary hypertension
- Splenic sequestration
- Stroke
- Death
In one case, a patient taking Oxbryta experienced more frequent vaso-occlusive crises after starting the medication than he had before. Along with pain and swelling, the man later suffered a stroke while on Oxbryta.
By filing an Oxbryta lawsuit, you may be able to get help paying for medical bills, lost wages, and more.
Get Help from Our Oxbryta Lawsuit Lawyers
At Sokolove Law, our Oxbryta lawsuit lawyers can seek justice for patients who have suffered as a result of taking this medication.
As a national law firm, we can work with families in all 50 states to pursue compensation from an Oxbryta lawsuit.
To date, our team has secured more than $1.6 Billion for families impacted by dangerous drugs and medical devices.
There are no upfront costs or hourly fees to work with our Oxbryta lawyers, so you can get the help you deserve without any financial risk.
Call (800) 995-1212 now or fill out our contact form to get started with a free, no-obligation case review.
Oxbryta Injury Lawsuit FAQs
Who makes Oxbryta?
Oxbryta was made by Global Blood Therapeutics Inc., which is owned by Pfizer, Inc. Oxbryta lawsuits filed against these companies claim they failed to warn patients about the risks associated with taking Oxbryta.
Get a free case review now if you or a loved one suffered serious side effects from this medication. You may be eligible for compensation from an Oxbryta lawsuit.
Why is Oxbryta being discontinued?
Oxbryta is being discontinued because the medication may increase the risk of vaso-occlusive crisis in patients with sickle cell disease, which can cause severe pain and even death.
The drug’s manufacturer recalled the medication after determining the risks associated with Oxbryta outweighed the benefits.
Is there an Oxbryta class action lawsuit?
At this time, Oxbryta claims have not been consolidated into a class action lawsuit or multidistrict litigation. Instead, victims can file individual Oxbryta lawsuits against the drug’s manufacturer.
How much does it cost to work with an Oxbryta attorney?
At Sokolove Law, there are no upfront costs or hourly fees to work with our Oxbryta attorneys.
We work on a contingency-fee basis, which means you pay nothing unless we secure compensation on your behalf.
Call (800) 995-1212 now to see if our team can fight for you.
